["{\n\"step_by_step_thinking\": \"The question is about CRISPR/Cas12a technology for detecting EGFR mutations in circulating DNA. There are no relevant documents provided about CRISPR/Cas12a or its application to detect EGFR mutations. The only mentions of EGFR are in the context of epidermal growth factor receptor gene expression and amplification in neuroepithelial tumours, which is a different scenario than detecting mutations in circulating DNA.\",\n\"answer_choice\": \"B\""]